Whether your business is based here in Florida or elsewhere in the U.S., in most instances, buyers derive their value based on a multiple of the company’s earnings before Interest, taxes, depreciation and amortization or “EBITDA” as the parlance goes. While EBITDA may be a word that gets tossed around commonly in the M&A community […]
After all the time and effort you have spent building your company you cannot afford to entrust its sale in the hands of someone who will not absolutely maximize the value of what you have built.
Ready to sell you business and retire? From picking a successor to finding the right buyer you’ve got some big issues to consider. Sharon Epperson walks you through the steps that will leave your business in good hands so you can Retire Well.
Nevertheless, there is GOOD NEWS! This is also a time that companies and individuals are looking for growth and income strategies. Acquisitions are a proven growth strategy for many businesses.
That statement is true of business valuations too. If your sales and profits are growing then your multiple grows. If your business revenues and profits are down then your multiple will be down.
The pharmaceutical industry saw a flurry of mergers and acquisitions this year, but none was more complicated than this one. Novartis AG (NVS) and GlaxoSmithKline (GSK) agreed to swap $20 billion in assets in what amounted to major restructurings for both firms.
#9: Top Mergers and Acquisitions: Facebook Inc (FB) and WhatsApp – Facebook Inc (FB) has a reputation for headline-grabbing acquisitions, but no deal it did in 2014 generated as much heat and light as its purchase of WhatsApp.
Compound pharmacies have been in the news with plenty of negative headlines since the meningitis issue created at the NECC pharmacy. This has created a series of changes in the industry on a state by state basis, and federally.
2015 is shaping up to be a very big year for M&A, IPOs due to the low cost of capital, the US economy expanding, and higher valuations.
Generally, an investment banker is working on large transactions such as raising $100mm for a company to continue to expand, or selling a large company with $200mm in revenues.
